Rendering

Component: (Network and Table)
Network
034 - Disclosure - Note 11 - Convertible Preferred Stock Warrant Liability (Tables)
(http://www.biocardia.com/20161231/role/statement-note-11-convertible-preferred-stock-warrant-liability-tables)
TableStatement [Table]
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000925741 (http://www.sec.gov/CIK)
Scenario [Axis]Scenario, Unspecified [Domain]
Statement [Line Items]Period [Axis]
2016-01-01 - 2016-12-31
Notes Tables
 
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
 
 
Exercise
 
 
Value
  
 
 
  
 
 
Shares
 
 
Estimated Fair Value
 
 
 
price
 
 
at grant
  
 
Issue
  
Expiration
 
December 31,
 
 
December 31,
 
Share class
 
per share
 
 
date
  
 
date
  
date
 
2015
 
 
2015
 
Series D
   $
0.37
    $
0.30
   
January 2006
  
January 2016
    
325,861
    $
2
 
Series D
   $
0.37
    $
0.30
   
July 2007
  
July 2017
    
203,691
     
20
 
Series D
   $
0.37
    $
0.30
   
August 2007
  
August 2017
    
203,691
     
20
 
Series D
   $
0.37
    $
0.30
   
September 2007
  
September 2017
    
203,691
     
20
 
Series F
   $
0.64
    $
0.27
   
April 2013
  
April 2016
    
888,176
     
94
 
Series F
   $
0.64
    $
0.28
   
April 2013
  
October 2017
    
482,699
     
115
 
Series F
   $
0.64
    $
0.28
   
April 2013
  
November 2017
    
11,620
     
3
 
Series F
   $
0.64
    $
0.27
   
May 2013
  
May 2016
    
13,169
     
1
 
     
 
      
 
    
 
  
 
    
2,332,598
    $
275
 
  
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]
 
 
December 31, 2015
 
Risk-free interest rate
  
0.14
 –
0.86%
  
Volatility
  
98.5
 –
116.25%
  
Dividend yield
  
None
  
Contractual term (in years)
  
0.1
 –
1.8